The only thing that really matters now is an FDA approval, provisional or final, for AD based on an NDA for the 2b/3 trial. After that, none of the involved (and self-involved) speculations about the need for a confirmatory trial, the timing of a confirmatory trial, or the nature of a confirmatory trial, has more than minor significance.